Pfizer, Inc.

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse Other stock markets 21:00:02 17/01/2025 GMT			5-day change	1st Jan Change
26.30 ^USD	-0.72%		-1.87%	-0.87%

01-17	Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks	MT
01-17	USA: 15 new drugs on the negotiation list	CF

Haleon says Pfizer representative steps down from board

December 05, 2024 at 10:56 am

Haleon PLC - Weybridge, Surrey-based consumer healthcare products - Says Pfizer Inc representative and Non-Executive Director, David Denton, stepped down from Haleon's board on Wednesday following the reduction of Pfizer's stake in Haleon to below 20% and in line with the two firms' relationship agreement. Current Chief Financial Officer of J Sainsbury PLC Blathnaid Bergin will join the Haleon board as non-executive director on February 24.

Current stock price: 377.13 pence, down 0.2% in London on Thursday morning

12-month change: up 17%

By Emily Parsons, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Stocks mentioned in the article

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
HALEON PLC	365.85GBX	-2.02%	0.00%	41.58B
J SAINSBURY PLC	260.40GBX	-1.66%	+3.41%	7.52B
PFIZER, INC.	26.30USD	-0.72%	-1.87%	149B

Latest news about Pfizer, Inc.

Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks	01-17	MT
USA: 15 new drugs on the negotiation list	01-17	CF
Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks	01-17	MT
Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks	01-17	MT
US has chosen drugs to negotiate for Medicare	01-17	FW
BioXcel Therapeutics, Inc. Appoints Rajiv Patni to the Board	01-16	CI
Pfizer Reportedly to Sell $3.05 Billion Worth of Haleon Shares	01-16	MT
Global markets live: Boeing, Pfizer, Nvidia, Goldman Sachs, Shell...	01-15
Wall Street rallies on inflation and earnings bonanza	01-15
Pfizer Appeals Ruling on $75.2 Million Insider Trading Settlement	01-15	MT
Pfizer Reportedly to Sell $3.05 Billion Worth of Haleon Shares	01-15	MT
Haleon: Pfizer continues to withdraw from the capital	01-15	CF
FTSE 100 : UK inflation cools, markets heat up	01-15
Pfizer cuts stake in Haleon to 7% in GBP2.5 billion share sale	01-15	AN
Pfizer Sells GBP2.5 Billion of Haleon Shares	01-15	MT
Pfizer Sells 700 Million Haleon Shares for $3.05 Billion	01-15	DJ
Stocks to rise as UK consumer inflation slows	01-15	AN
Pfizer to Sell 7.7% Stake in Haleon via Secondary Offering	01-15	MT
Pfizer appeals denial of $75 million claim in SEC case against Cohen hedge fund	01-14	RE
Health Care Slides After Lilly Warning - Health Care Roundup	01-14	DJ
Sector Update: Health Care Stocks Slide Late Afternoon	01-14	MT
Sector Update: Health Care Stocks Fall Tuesday Afternoon	01-14	MT
Pfizer to more than halve Haleon holding in GBP2.57 billion sale	01-14	AN
Pfizer to Cut Haleon Stake	01-14	DJ
Pfizer intends to cut stake in Sensodyne-maker Haleon to 7.3%, says bookrunner	01-14	RE

David Denton

Presently, David M. Denton holds the position of Chief Financial Officer & Executive Vice President at Lowe's Cos., Inc. He is also on the board of Tapestry, Inc. Mr. Denton previously held the position of Chief Financial Officer & Executive Vice President at CVS Health Corp. Chief Financial Officer & Executive Vice President for CVS Pharmacy, Inc. and Chief Financial Officer & Controller for Caremark PhC LLC (both are subsidiaries of CVS Health Corp.). He received an undergraduate degree from Kansas State University and an MBA from The Wake Forest University School of Business.

View full profile

Chart Pfizer, Inc.

Duration

Period

PFE: Dynamic Chart

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (52.3%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (25.6%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (19.9%); - other (2.2%). Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (33.8%).

Employees

88,000

Sector

Pharmaceuticals

Calendar

23/01/2025 - Détachement de

More about the company